SABRes: in silico detection of drug resistance conferring mutations in subpopulations of SARS-CoV-2 genomes
Description
The emergence of resistance to antiviral drugs increasingly used to treat SARS-CoV-2 infections has been recognised as a significant threat to COVID-19 control. In addition, some SARS-CoV-2 variants of concern appear to be intrinsically resistant to
